8-K

                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549

                                FORM 8-K

                             CURRENT REPORT

                PURSUANT TO SECTION 13 OR 15(d) OF THE
                    SECURITIES EXCHANGE ACT OF 1934


   Date of Report (Date of earliest event reported)  December 23, 2002


                     BIO-RAD LABORATORIES, INC.
   _________________________________________________________________
           (Exact Name of Registrant as Specified in Charter)


   A Delaware Corporation             1-7928              94-1381833
   _________________________________________________________________
   (State or Other Jurisdiction     (Commission        (IRS Employer
      of Incorporation)              File  Number)  Identification No.)


   1000 Alfred Nobel Drive, Hercules, California               94547
   _________________________________________________________________
   (Address of Principal Executive Offices)                 (Zip Code)

   Registrant's telephone number, including area code  (510)724-7000


                               No Change
   _________________________________________________________________
     (Former Name or Former Address, if Changed Since Last Report)










   

   ITEM 5.  OTHER EVENTS.

        On December 23, 2002, Bio-Rad Laboratories, Inc. ( Bio-Rad ),
        issued a press release, the text of which is attached hereto
        as Exhibit 99.1, announcing executive management transition plans.


   ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.

   (c)  Exhibits.


      99.1           Press Release dated December 23, 2002 referred to in
                     Item 5 above.



                               SIGNATURES

   Pursuant to the requirements of the Securities Exchange Act of
   1934, the registrant has duly caused this report to be signed on
   its behalf by the undersigned hereunto duly authorized.

                                 BIO-RAD LABORATORIES, INC.
                                        (Registrant)


   Date:  December 23, 2002          By: /s/ James R. Stark
                                     James R. Stark
                                     Corporate Controller

EX-99

EXHIBIT 99.1



FOR IMMEDIATE RELEASE



Bio-Rad Announces Management Transition
Norman Schwartz To Succeed Founder David Schwartz As President And CEO;
Chief Operating Officer James Bennett To Retire


HERCULES, CA - December 23, 2002 - Bio-Rad Laboratories, Inc.
(AMEX: BIO and BIO.B), a multinational manufacturer and distributor of life
science research products and clinical diagnostics, announced executive
management transition plans today. On January 1, 2003, Norman Schwartz,
Bio-Rad's Vice President and Group Manager of Life Science will assume the
position of President and Chief Executive Officer. He will replace
David Schwartz, founder of Bio-Rad, who will continue to maintain an active
role in the company as Chairman of the Board. Additionally, Executive Vice
President and Chief Operating Officer James Bennett will retire but will
continue to serve on the Board of Directors.

"We have great confidence in the new generation of Bio-Rad leadership," said
outgoing President and CEO David Schwartz. "Norman has extensive experience
managing all aspects of the business and has played an active role in the
growth and expansion of the company. We look forward to building on that
success in the future."

Norman Schwartz has been with Bio-Rad Laboratories since 1974 and has held a
variety of positions with the company, both domestically and internationally,
including Corporate Treasurer, General Manager for manufacturing operations
in the United Kingdom, Manager of Bio-Rad's Japanese subsidiary and
Vice President and Group Manager of Clinical Diagnostics. He was appointed a
Director of the company in 1995, and since 1997, has been Vice President and
Group Manager of Life Science.

Chief Operating Officer James J. Bennett has been with Bio-Rad for 26 years.
He has served as Executive Vice President and Chief Operating Officer since
1993. "We congratulate and thank Jim for his many years of dedicated service
to the company and we wish him all the best in the years to come," said
David Schwartz.

David Schwartz has led Bio-Rad as President, Chief Executive Officer and
Chairman of the Board since he and his wife Alice N. Schwartz, a biochemist,
co-founded the company in 1952. Under his guidance, Bio-Rad has grown to more
than $800 million in revenues.

Bio-Rad Laboratories, Inc. (www.bio-rad.com) is a multinational manufacturer
and distributor of life science research products and clinical diagnostics.
It is based in Hercules, California, and serves more than 70,000 research
and industry customers worldwide through a network of more than 30 wholly
owned subsidiary offices.

Various statements made within this press release may constitute
"forward-looking statements" for purposes of the Securities and Exchange
Commission's "safe harbor" provisions under the Private Securities Litigation
Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934.
The forward-looking statements contained herein involve risks and
uncertainties that could cause results to differ materially from the Company's
expectations.



For more information, contact:
Ron Hutton, Treasurer
Bio-Rad Laboratories, Inc.
Phone: (510) 724-7000
E-mail: ron_hutton@bio-rad.com